Literature DB >> 33538979

Frequency and influence of "not relevant" responses on the Dermatology Life Quality Index among adults with atopic dermatitis.

John S Barbieri1,2, Zelma C Chiesa Fuxench3, Daniel B Shin3, Junko Takeshita3,4.   

Abstract

PURPOSE: "Not relevant" responses (NRRs) on the Dermatology Life Quality Index (DLQI) are common among adults with psoriasis and may be associated with underestimation of disease burden. Little is known about "not relevant" responses among adults with atopic dermatitis. We aimed to examine the frequency of NRRs on the DLQI and to determine whether NRRs are associated with underestimation of disease burden among adults with atopic dermatitis.
METHODS: Adults with atopic dermatitis were identified and evaluated via online survey. We evaluated the frequency of NRRs on the DLQI, stratified by sociodemographic characteristics. To examine the association between NRRs and other measures of disease burden, Patient-Oriented Eczema Measure (POEM), Patient-Oriented SCORAD (PO-SCORAD), and Short-Form (SF)-12 scores were compared between those who responded "not relevant" versus "not at all".
RESULTS: Among 764 adults with atopic dermatitis, most had mild disease. The median (interquartile range [IQR]) POEM, PO-SCORAD, and DLQI scores were 5 (2-10), 24 (14-34), and 2 (1-6), respectively. Most (55.2%) also had at least one NRR, and 17.9% had 4 or more "not relevant" responses, with differences across several sociodemographic characteristics. There were no substantial differences in SF-12, POEM, and PO-SCORAD scores between those who responded "not relevant" versus "not at all".
CONCLUSION: NRRs on the DLQI are common among adults with atopic dermatitis and differ across sociodemographic characteristics, suggesting issues with content validity. There is not a clear association between NRRs and other measures of disease severity among adults with mostly mild atopic dermatitis.

Entities:  

Keywords:  Atopic dermatitis; Dermatology Life Quality Index; Eczema; Health-related quality of life; Not relevant response; Quality of life

Mesh:

Year:  2021        PMID: 33538979      PMCID: PMC8178230          DOI: 10.1007/s11136-021-02770-z

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   3.440


  31 in total

Review 1.  Patient-Oriented Eczema Measure (POEM), a core instrument to measure symptoms in clinical trials: a Harmonising Outcome Measures for Eczema (HOME) statement.

Authors:  P I Spuls; L A A Gerbens; E Simpson; C J Apfelbacher; J R Chalmers; K S Thomas; C A C Prinsen; L B von Kobyletzki; J A Singh; H C Williams; J Schmitt
Journal:  Br J Dermatol       Date:  2017-03-02       Impact factor: 9.302

2.  Evaluation of the Dermatology Life Quality Index scoring modification, the DLQI-R score, in two independent populations.

Authors:  J S Barbieri; J M Gelfand
Journal:  Br J Dermatol       Date:  2018-12-19       Impact factor: 9.302

3.  Translating the science of quality of life into practice: What do dermatology life quality index scores mean?

Authors:  Yan Hongbo; Charles L Thomas; Michael A Harrison; M Sam Salek; Andrew Y Finlay
Journal:  J Invest Dermatol       Date:  2005-10       Impact factor: 8.551

4.  Validation of the U.K. diagnostic criteria for atopic dermatitis in a population setting. U.K. Diagnostic Criteria for Atopic Dermatitis Working Party.

Authors:  H C Williams; P G Burney; A C Pembroke; R J Hay
Journal:  Br J Dermatol       Date:  1996-07       Impact factor: 9.302

5.  Evaluation of 'not relevant' responses on the Dermatology Life Quality Index (DLQI) and the DLQI-R scoring modification among Indian patients with vitiligo.

Authors:  V Gupta; N Taneja; H C Sati; V Sreenivas; M Ramam
Journal:  Br J Dermatol       Date:  2020-09-10       Impact factor: 9.302

6.  A detailed analysis of 'not relevant' responses on the DLQI in psoriasis: potential biases in treatment decisions.

Authors:  F Rencz; A K Poór; M Péntek; P Holló; S Kárpáti; L Gulácsi; A Szegedi; É Remenyik; B Hidvégi; K Herszényi; H Jókai; Z Beretzky; V Brodszky
Journal:  J Eur Acad Dermatol Venereol       Date:  2017-11-28       Impact factor: 6.166

7.  Does the Dermatology Life Quality Index (DLQI) underestimate the disease-specific burden of psoriasis patients?

Authors:  A Langenbruch; M A Radtke; M Gutknecht; M Augustin
Journal:  J Eur Acad Dermatol Venereol       Date:  2018-09-27       Impact factor: 6.166

8.  Atopic Dermatitis in America Study: A Cross-Sectional Study Examining the Prevalence and Disease Burden of Atopic Dermatitis in the US Adult Population.

Authors:  Zelma C Chiesa Fuxench; Julie K Block; Mark Boguniewicz; John Boyle; Luz Fonacier; Joel M Gelfand; Mitchell H Grayson; David J Margolis; Lynda Mitchell; Jonathan I Silverberg; Lawrence Schwartz; Eric L Simpson; Peck Y Ong
Journal:  J Invest Dermatol       Date:  2018-10-30       Impact factor: 8.551

9.  COSMIN methodology for evaluating the content validity of patient-reported outcome measures: a Delphi study.

Authors:  C B Terwee; C A C Prinsen; A Chiarotto; M J Westerman; D L Patrick; J Alonso; L M Bouter; H C W de Vet; L B Mokkink
Journal:  Qual Life Res       Date:  2018-03-17       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.